NEW YORK (GenomeWeb) – A significant majority of Americans are not familiar with personalized medicine, but when told how it could be used to tailor treatments or to assess their disease risk, they believe insurance companies should cover such technologies, according to the results of a survey published today.

When the concept and practice of personalized medicine was explained to those who had not heard about it before — and examples were provided of tests that are already in use — around 65 percent of respondents had a positive reaction to it.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.